Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health

This article argues that the UK-US pharmaceuticals trade deal, announced on 1 December 2025, will harm public health by diverting billions of pounds from NHS funding to pay higher prices for branded medicines. The deal secures 0% tariffs on UK pharmaceutical exports to the US but